FRANCE BED HOLDINGS CO., LTD. (7840) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

30.7 k

Shareholding (Dec 2020)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 51.49

Poor long term growth as Net Sales has grown by an annual rate of 2.93% over the last 5 years

Flat results in Jun 25

With ROE of 7.28%, it has a very attractive valuation with a 1.20 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 49,341 Million (Small Cap)

P/E

16.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.06

Return on Equity

7.22%

Price to Book

1.28

Revenue and Profits:

Net Sales:

14,362 Million

(Quarterly Results - Jun 2025)

Net Profit:

477 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.32%

6 Months

4.91%

1 Year

5.66%

2 Years

4.25%

3 Years

42.02%

4 Years

45.6%

5 Years

53.53%

FRANCE BED HOLDINGS CO., LTD. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.93%

EBIT Growth (5y)

13.51%

EBIT to Interest (avg)

51.49

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.05

Sales to Capital Employed (avg)

1.17

Tax Ratio

35.92%

Dividend Payout Ratio

46.91%

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

11.27%

ROE (avg)

7.19%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.20

EV to EBIT

9.95

EV to EBITDA

4.66

EV to Capital Employed

1.21

EV to Sales

0.77

PEG Ratio

Dividend Yield

ROCE (Latest)

12.17%

ROE (Latest)

7.28%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2020

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -3.06% vs 6.06% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -26.95% vs 6.01% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,362.00",
          "val2": "14,815.00",
          "chgp": "-3.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,110.00",
          "val2": "2,398.00",
          "chgp": "-12.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.00",
          "val2": "20.00",
          "chgp": "-10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "477.00",
          "val2": "653.00",
          "chgp": "-26.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "54.50%",
          "val2": "69.60%",
          "chgp": "-1.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 2.38% vs 0.98% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -6.00% vs 15.99% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "60,561.00",
          "val2": "59,151.00",
          "chgp": "2.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10,025.00",
          "val2": "10,188.00",
          "chgp": "-1.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "76.00",
          "val2": "83.00",
          "chgp": "-8.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-30.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,946.00",
          "val2": "3,134.00",
          "chgp": "-6.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "77.60%",
          "val2": "77.60%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

14,362.00

14,815.00

-3.06%

Operating Profit (PBDIT) excl Other Income

2,110.00

2,398.00

-12.01%

Interest

18.00

20.00

-10.00%

Exceptional Items

0.00

Consolidate Net Profit

477.00

653.00

-26.95%

Operating Profit Margin (Excl OI)

54.50%

69.60%

-1.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -3.06% vs 6.06% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -26.95% vs 6.01% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

60,561.00

59,151.00

2.38%

Operating Profit (PBDIT) excl Other Income

10,025.00

10,188.00

-1.60%

Interest

76.00

83.00

-8.43%

Exceptional Items

-30.00

0.00

Consolidate Net Profit

2,946.00

3,134.00

-6.00%

Operating Profit Margin (Excl OI)

77.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 2.38% vs 0.98% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -6.00% vs 15.99% in Mar 2024

All Annual Results

Company CV

About FRANCE BED HOLDINGS CO., LTD.

FRANCE BED HOLDINGS CO., LTD.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available